Company: CGC
Filing Date: 2025-05-30
Form Type: POS AM
Source: 0001104659-25-054925
Chunk: 57

Company: Canopy Growth Corp
Filing Date: 2025-05-30
Form: POS AM
Chunk 57
---
 of March 31, 2025 under the Omnibus Incentive Plan at a weighted average exercise price of $22.81 (C$32.81) per Common Share;

•

up to 1,286,224 Common Shares issuable upon the vesting of restricted share units outstanding under the Omnibus Incentive Plan;

•

up to 73,461 Common Shares issuable upon the vesting of performance share units outstanding under the Omnibus Incentive Plan;

•

up to 13,377,930 Common Shares available for future issuance under the Omnibus Incentive Plan, based on the Common Shares outstanding as of March 31, 2025 (the Omnibus Incentive Plan provides that the aggregate number of Common Shares reserved for issuance for awards granted under the Omnibus Incentive Plan and under all other equity plans of the Company shall not exceed 10% of the Company’s total issued and outstanding Common Shares from time to time);

•

up to 15,483,580 Common Shares issuable upon exercise of Warrants with a weighted average exercise price of $7.28 (C$10.47) per Common Share;

•

up to 8,239 Common Shares issuable upon the conversion of the convertible debentures due September 2025 issued by the Company’s wholly-owned subsidiary, The Supreme Cannabis Company, Inc.;

•

up to 6,700,860 Common Shares issuable upon the conversion of the Company’s convertible debentures due May 2029 with a conversion price of C$14.38 per Common Share; and

•

68,469 Common Shares issuable in connection with Canopy USA’s acquisition of the minority interests of certain subsidiaries of Acreage.

For information regarding the number of Common Shares outstanding and issuable upon exercise or conversion of the foregoing instruments, in each case, as of May 28, 2025, see “Summary — The Offering” in this prospectus supplement.

To the extent that any of these Common Shares are issued upon conversion, exercise or vesting of any of the foregoing instruments or otherwise, investors purchasing our Common Shares in this offering may experience further dilution. In addition, we may choose to raise additional capital due to market conditions or strategic considerations even if we believe we have sufficient funds for our current or future operating plans. To the extent that we raise additional capital through the sale of equity or convertible debt securities, the issuance of these securities could result in further dilution to our shareholders. See “Risk Factors —